4.7 Review

Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels

期刊

EUROPEAN JOURNAL OF PHARMACOLOGY
卷 490, 期 1-3, 页码 159-168

出版社

ELSEVIER
DOI: 10.1016/j.ejphar.2004.02.053

关键词

type 1 diabetes; diabetic encephalopathy; cognition; insulin; cerebrovascular alteration; hypoglycaemia

向作者/读者索取更多资源

Type I diabetes can lead to several well-described complications such as retinopathy, nephropathy and peripheral neuropathy. Evidence is accumulating that it is also associated with gradually developing end-organ damage in the central nervous system. This relatively unknown complication can be referred to as 'diabetic encephalopathy' and is characterised by electrophysiological and neuroradiological changes, such as delayed latencies of evoked potentials, modest cerebral atrophy and (periventricular) white matter lesions. Furthermore, individuals with type 1 diabetes may show performance deficits in a wide range of cognitive domains. The exact mechanisms underlying this diabetic encephalopathy are only partially known. Chronic metabolic and vascular changes appear to play an important role. Interestingly, the differences in the 'cognitive profile' between type I and type 2 diabetes also suggest a critical role for disturbances of insulin action in the central nervous system. (C) 2004 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据